News | April 22, 2015

Higher field strength improves image quality but raises concerns about radiation dose to the fetus

April 22, 2015 — Although ultrasound remains the primary imaging modality used in prenatal imaging, fetal magnetic resonance imaging (MRI) is playing an increasing role in further evaluation of fetuses suspected of congenital anomalies. As 3-T MRI scanners become more common due to their improved image signal-to-noise ratio and anatomical detail, the benefits of 3-T MRI must be weighed against potential risks to the fetus that may result from the higher field strength.

"MRI is playing an increasingly important role in the assessment of complex prenatal disease," said Kathleen E. Carey, M.D., Mayo Clinic, Jacksonville, Florida. "The use of stronger 3-T field strengths may allow for improved visualization of subcutaneous fat and osseous structures, including the hands and feet of the developing fetus."

The study is featured in an electronic exhibit at the American Roentgen Ray Society (ARRS) 2015 annual meeting in Toronto.

First attempted in the 1980s, MRI in pregnancy has maintained a steady growth rate. Recent studies have demonstrated that fetal MRI not only provides good detail of normal fetal anatomy and allows characterization of suspected anomalies but also may alter the diagnosis provided by ultrasound, uncovering fetal anomalies earlier and more accurately. Currently, clinical MRI is most frequently performed on 1.5-T MRI systems, but 3-T scanners are becoming more common around the world as the search for improved image signal-to-noise ratio and anatomic detail grows. This developmental opportunity must be weighed against potential risks to the fetus, taking into account the specific absorption rate.

ARRS will present a series of fetal MRI cases and discuss the anatomic and imaging findings, indication for MRI, diagnosis and impact on patient management. The benefits and limitations of fetal MRI at 1.5-T and 3-T field strengths will be discussed, and future advanced imaging will be considered, including spectroscopy and diffusion tensor imaging.

For more information: www.arrs.org


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Clinical Trials

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...

Time June 27, 2024
arrow
News | Pediatric Imaging

June 25, 2024 — Rady Children’s Hospital-San Diego, one of the nation’s top pediatric health care systems, today ...

Time June 25, 2024
arrow
News | MRI Breast

June 12, 2024 — Royal Philips recently announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet ...

Time June 12, 2024
arrow
News | Radiology Business

May 29, 2024 — Strategic Radiology added a third California member to the nation’s leading coalition of independent ...

Time May 29, 2024
arrow
Subscribe Now